EZH2 and pancreatic neoplasm: In other types of human cancer, in contrast, Wei et al reported that loss of H3K27me3 correlated with poor prognosis of patients with breast, ovarian, and pancreatic cancers, in which no association was observed between expression of H3K27me3 and EZH2 [14].